Camp4 Therapeutics Ratios (2023-2025) | CAMP

Ratios Sep2023 Dec2023 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -3,341.71%-2,036.66%-1,458.28%-840.01%-1,663.90%
EBIT Margin -3,525.14%-2,152.45%-1,526.81%-870.27%-1,717.11%
EBITDA Margin -3,341.71%-2,036.66%-1,449.07%-840.81%-1,899.25%
Operating Margin -3,525.14%-2,152.45%-1,526.81%-870.27%-1,717.11%
Net Margin -3,341.71%-2,036.66%-1,458.28%-840.01%-1,663.90%
FCF Margin -1,777.45%-1,699.18%-689.98%-1,410.94%
Efficiency
Assets Average 49.84M70.54M57.02M68.83M
Equity Average -117.64M-47.92M57.36M45.78M49.33M
Invested Capital -111.55M-123.73M-158.97M63.30M51.67M40.07M58.74M
Asset Utilization Ratio 0.010.020.050.06
Leverage & Solvency
Interest Coverage Ratio -262.51-162.36-218.0096.79
Equity Ratio -2.25-7.440.810.820.780.68
Times Interest Earned -262.51-162.36-218.0096.79
Valuation
Enterprise Value -50.47M-38.38M-2.53M-64.04M-49.32M-39.10M-75.30M
Return Ratios
Return on Sales -33.42%-141.71%-20.37%-14.58%-8.40%-16.64%
Return on Capital Employed -1.32%-0.83%-1.08%-0.88%
Return on Assets -1.04%-0.73%-0.91%-0.75%
Return on Equity 1.08%-0.90%-1.13%-1.05%